Laval, Canada – (BUSINESSWIRE) – 8 February 2023 – We are pleased to announce that the 3rd edition of Sweet Biopharma Day will be held, in person, on April 12, 2023. This unique, by invitation-only event invites young Canadian biotechs to submit an application for a chance to present in front of key global biopharma companies, as well as leading Canadian life sciences ecosystem’s stakeholders (such as venture capitalists and representatives from governments and associations). The intent is to develop potential collaborations or partnerships.
Are you a biotechnology start-up or company with fewer than 25 employees and focused on innovative research and development? Do you have a strong commercial potential? You can apply for the chance to be among the 16 promising Canadian biotech companies, the “Sweet 16”, who will be invited to present in front of key biopharmaceutical industry stakeholders on April 12th.
How to apply: Companies must provide a 2-page executive summary and a short presentation (one set of no more than 5 slides) describing their cutting-edge technology, target indications, and points of differentiation. Application packages must be submitted via this form no later than Wednesday, March 8, 2023, at 11:59 p.m. EDT. The pharmaceutical companies taking part will select the 16 participating companies, who will be notified no later than March 29, 2023.
This event is the perfect opportunity for promising companies to network. The “Sweet 16” company with the best presentation will be awarded a $2,500 prize at the end of the event, a ‘’Prix Coup de Coeur’’ will also be awarded.
The Sweet Biopharma Day is generously financially supported by its Gold sponsor, Fonds de solidarité FTQ, its Silver sponsors, Innovative Medecines Canada, adMare BioInnovations, RBCx, Investissement Québec, Robic and Mispro Biotech Services, its Bronze sponsors Inversago , Amorchem, CTI Fonds Sciences de la vie, Thermo Fisher Scientific and Agilent, and Maple sponsors RBCx and Sciex.
About Sweet Biopharma Day
The Sweet Biopharma Day is a Canadian life sciences by invitation-only event. Its third edition is being organized by BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations. It provides executives from young biotech companies with a unique opportunity to directly interact with international pharmaceutical companies and key venture capital firms to develop synergistic partnerships.
- Gaëlle Bridon, BIOQuébec, T: 001-438-520-4700, email@example.com